Clinical trial NCT03287271 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2026-04-01 → 2025-03-12 3. primary completion date: 2025-04-01 → 2023-07-30 4. enrollment: 90 → 8 participants 5. enrollment type: ESTIMATED → ACTUAL 6. allocation: NA → NON_RANDOMIZED
Clinical trial NCT06613100 updates: 1. completion date: 2030-01-23 → 2030-03-04 2. primary completion date: 2027-01-22 → 2027-02-17
Clinical trial NCT06693609 updates: 1. start date: 2025-04-15 → 2025-05-08 2. completion date: 2026-02-12 → 2025-12-10 3. primary completion date: 2026-02-12 → 2025-12-10
Clinical trial NCT07549490: start date: 2026-08-04 → 2026-08-05.
Clinical trial NCT07504601: start date: 2026-08-04 → 2026-08-05.
Clinical trial NCT06993792: enrollment: 1200 → 1400 participants.
Clinical trial NCT07477275 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07295951 updates: 1. completion date: 2026-07-13 → 2026-09-29 2. primary completion date: 2026-06-14 → 2026-09-29
Clinical trial NCT07230860 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 180 → 189 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT04812366 updates: 1. completion date: 2026-04-01 → 2027-06-01 2. primary completion date: 2026-04-01 → 2027-06-01